Awards & Advancement

CeNeRx completes $4.85 million financing round

Monday, December 12, 2011 11:28 AM

CeNeRx BioPharma has completed a $4.85 million financing. Existing investors Perseus Soros Biopharmaceutical Fund, L Capital Partners, Pappas Ventures and Omega Funds all participated in the financing. CeNeRx plans to use the proceeds to complete its ongoing phase II trial of the improved formulation of its novel antidepressant TriRima as monotherapy in treatment resistant depression, as well as to support advancement of its pipeline for a variety of CNS disorders.

More... »

BioSpecifics names Gould to board of directors

Friday, December 9, 2011 10:48 AM

BioSpecifics Technologies has named George Gould to its board of directors effective December 6, 2011. Gould, an attorney, is principal of George M. Gould and of counsel to Gibbons PC.

More... »

Fang joins SRI as director of clinical manufacturing

Thursday, December 8, 2011 02:09 PM

Jia-Hwa Fang, Ph.D., has joined SRI's biosciences division as director of clinical manufacturing. In this new role, he will lead a team to transfer and scale-up R&D, Good Laboratory Practice (GLP), and pilot formulations for early stage clinical
trial materials in compliance with Good Manufacturing Practices (GMP). He will be responsible for developing technical, quality, and project specifications for studies in SRI's pharmaceutical clinical manufacturing facility.

More... »

Adams joins Auxilium Pharmaceuticals

Thursday, December 8, 2011 11:56 AM

Auxilium Pharmaceuticals has named Adrian Adams chief executive officer and president, effective immediately. Adams succeeds Armando Anido, who has agreed to step down as chief executive officer and president and has resigned as a member of the board of directors.

More... »

Essentialis names Berg CEO

Wednesday, December 7, 2011 10:31 AM

Essentialis has promoted Aaron D. Berg from president and chief commercial officer to chief executive officer. Berg joined Essentialis in 2010 bringing business development and product commercialization experience to the company. He was also appointed to the Essentialis board of directors.

More... »

Aratana Therapeutics raises $15m in Series B financing

Wednesday, December 7, 2011 10:01 AM

Aratana Therapeutics has closed a $15 million Series B financing, bringing the total capital raised since Aratana was launched earlier this year to $31 million.

More... »

Theraclone names Stocks CEO

Tuesday, December 6, 2011 02:41 PM

Theraclone Sciences has named Clifford J. Stocks chief executive officer.

More... »

Miclot joins Tengion

Tuesday, December 6, 2011 09:25 AM

Tengion has named John L. Miclot president and chief executive officer.

More... »

BioNano names Monroe CFO

Monday, December 5, 2011 02:57 PM

BioNano Genomics has named Garth Monroe chief financial officer. Monroe will report to president and chief executive officer Dr. R. Erik Holmlin.

More... »

Alexian Brothers Health System names president and CEO

Monday, December 5, 2011 09:48 AM

Mark A. Frey has been named president and chief executive officer of the Alexian Brothers Health System. He succeeds Brother Thomas Keusenkothen, C.F.A., who retired from the position on December 1, 2011.

More... »